Elvira De Leonibus Selected Research

Elvira De Leonibus Research Topics

Disease

6	Mucopolysaccharidosis III (Sanfilippo Syndrome) 01/2022 - 05/2013
6	Parkinson Disease (Parkinson's Disease) 12/2021 - 06/2007
6	Mucopolysaccharidoses 01/2021 - 05/2010
4	Inflammation (Inflammations) 01/2022 - 05/2010
2	Dementia (Dementias) 01/2021 - 01/2021
2	Lysosomal Storage Diseases (Lysosomal Storage Disease) 01/2020 - 07/2014
2	Mucopolysaccharidosis VI (Syndrome, Maroteaux-Lamy) 07/2014 - 03/2011
1	Rett Syndrome (Rett's Disorder) 01/2022
1	Synucleinopathies 12/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2021
1	Obesity 10/2021
1	Color Vision Defects (Color Blindness) 01/2020
1	Neuroinflammatory Diseases 01/2020
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2020
1	Cognitive Dysfunction 01/2020
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2019
1	Dyskinesias (Dyskinesia) 01/2018
1	Glycogen Storage Disease Type II (Pompe's Disease) 11/2017
1	Muscular Diseases (Myopathy) 11/2017
1	Multiple Sulfatase Deficiency Disease (Mucosulfatidosis) 05/2011
1	Cardiomyopathies (Cardiomyopathy) 01/2011
1	Disease Progression 01/2011
1	Catalepsy 06/2007

Drug/Important Bio-Agent (IBA)

7	SynucleinsIBA 12/2021 - 01/2018
5	Dopamine (Intropin)FDA LinkGeneric 12/2021 - 02/2009
4	GlycosaminoglycansIBA 01/2022 - 05/2010
4	Lysergic Acid Diethylamide (LSD)IBA 01/2020 - 05/2013
3	Levodopa (L Dopa)FDA LinkGeneric 12/2021 - 06/2007
3	EnzymesIBA 07/2014 - 05/2010
2	Heparitin Sulfate (Heparan Sulfate)IBA 01/2022 - 01/2021
2	Haloperidol (Haldol)FDA LinkGeneric 01/2021 - 06/2007
2	Amyloid (Amyloid Fibrils)IBA 01/2020 - 01/2020
2	N-sulfoglucosamine sulfohydrolase (sulfamidase)IBA 12/2019 - 05/2013
2	SulfatasesIBA 12/2019 - 05/2011
2	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 02/2009 - 06/2007
1	Mirtazapine (Rexer)FDA LinkGeneric 01/2022
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2022
1	Fluoxetine (Prozac)FDA LinkGeneric 01/2022
1	PlasticsIBA 12/2021
1	EndocannabinoidsIBA 10/2021
1	OrexinsIBA 10/2021
1	Therapeutic UsesIBA 01/2021
1	Estrogens (Estrogen)FDA Link 01/2021
1	SCH 23390IBA 01/2021
1	Prion ProteinsIBA 01/2020
1	CalciumIBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Retinaldehyde (Retinal)IBA 01/2020
1	alpha-SynucleinIBA 01/2020
1	Amyloidogenic ProteinsIBA 01/2020
1	CannabidiolIBA 01/2019
1	AntibodiesIBA 01/2019
1	DystrophinIBA 01/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019
1	cannabidivarinIBA 01/2019
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 11/2017
1	GlycogenIBA 11/2017
1	N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B)IBA 03/2011
1	deflazacortIBA 01/2011
1	SteroidsIBA 01/2011
1	1-aminocyclopentane-1,3,4-tricarboxylic acidIBA 06/2007

Therapy/Procedure

4	Therapeutics 01/2022 - 05/2013
1	Aftercare (After-Treatment) 01/2019